相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations
David M. Roy et al.
CANCER CELL (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
Adriana Olar et al.
ACTA NEUROPATHOLOGICA (2015)
CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas
Vincent Gleize et al.
ANNALS OF NEUROLOGY (2015)
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes
Claudio Giachino et al.
CANCER CELL (2015)
Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials
Johan M. Kros et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
CDKN2A Loss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II-III) Astrocytomas
Gerald F. Reis et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Mutational landscape and clonal architecture in grade II and III gliomas
Hiromichi Suzuki et al.
NATURE GENETICS (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients
Kaspar Draaisma et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Tatsuya Ozawa et al.
CANCER CELL (2014)
A new tumor suppressor role for the Notch pathway in bladder cancer
Theodoros Rampias et al.
NATURE MEDICINE (2014)
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
Patrick J. Killela et al.
ONCOTARGET (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data
Yuichi Shiraishi et al.
NUCLEIC ACIDS RESEARCH (2013)
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
A. Hunter Shain et al.
PLOS ONE (2013)
IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma
Daniel Gorovets et al.
CLINICAL CANCER RESEARCH (2012)
Genetic profile of astrocytic and oligodendroglial gliomas
Hiroko Ohgaki et al.
BRAIN TUMOR PATHOLOGY (2011)
Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think
Camille Lobry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Joerg Balss et al.
ACTA NEUROPATHOLOGICA (2008)
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Justin S. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Chromatin modifier enzymes, the histone code and cancer
H Santos-Rosa et al.
EUROPEAN JOURNAL OF CANCER (2005)
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays
Y Nannya et al.
CANCER RESEARCH (2005)
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
E Hernando et al.
NATURE (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Prognostic factors for survival in adult patients with cerebral low-grade glioma
F Pignatti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
